254 related articles for article (PubMed ID: 29617434)
1. Transcription factor compensation during mammary gland development in E2F knockout mice.
To B; Andrechek ER
PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434
[TBL] [Abstract][Full Text] [Related]
2. The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer.
Hollern DP; Honeysett J; Cardiff RD; Andrechek ER
Mol Cell Biol; 2014 Sep; 34(17):3229-43. PubMed ID: 24934442
[TBL] [Abstract][Full Text] [Related]
3. Division and apoptosis of E2f-deficient retinal progenitors.
Chen D; Pacal M; Wenzel P; Knoepfler PS; Leone G; Bremner R
Nature; 2009 Dec; 462(7275):925-9. PubMed ID: 20016601
[TBL] [Abstract][Full Text] [Related]
4. Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis.
Wu L; de Bruin A; Wang H; Simmons T; Cleghorn W; Goldenberg LE; Sites E; Sandy A; Trimboli A; Fernandez SA; Eng C; Shapiro C; Leone G
Oncogene; 2015 Jan; 34(1):119-28. PubMed ID: 24276244
[TBL] [Abstract][Full Text] [Related]
5. Mouse development with a single E2F activator.
Tsai SY; Opavsky R; Sharma N; Wu L; Naidu S; Nolan E; Feria-Arias E; Timmers C; Opavska J; de Bruin A; Chong JL; Trikha P; Fernandez SA; Stromberg P; Rosol TJ; Leone G
Nature; 2008 Aug; 454(7208):1137-41. PubMed ID: 18594513
[TBL] [Abstract][Full Text] [Related]
6. E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3.
Chen D; Chen Y; Forrest D; Bremner R
Cell Death Differ; 2013 Jul; 20(7):931-40. PubMed ID: 23558950
[TBL] [Abstract][Full Text] [Related]
7. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a.
Chen D; Opavsky R; Pacal M; Tanimoto N; Wenzel P; Seeliger MW; Leone G; Bremner R
PLoS Biol; 2007 Jul; 5(7):e179. PubMed ID: 17608565
[TBL] [Abstract][Full Text] [Related]
8. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
Chong JL; Wenzel PL; Sáenz-Robles MT; Nair V; Ferrey A; Hagan JP; Gomez YM; Sharma N; Chen HZ; Ouseph M; Wang SH; Trikha P; Culp B; Mezache L; Winton DJ; Sansom OJ; Chen D; Bremner R; Cantalupo PG; Robinson ML; Pipas JM; Leone G
Nature; 2009 Dec; 462(7275):930-4. PubMed ID: 20016602
[TBL] [Abstract][Full Text] [Related]
9. Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs.
Clijsters L; Hoencamp C; Calis JJA; Marzio A; Handgraaf SM; Cuitino MC; Rosenberg BR; Leone G; Pagano M
Mol Cell; 2019 Jun; 74(6):1264-1277.e7. PubMed ID: 31130363
[TBL] [Abstract][Full Text] [Related]
10. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G
Cell Growth Differ; 2002 May; 13(5):215-25. PubMed ID: 12065245
[TBL] [Abstract][Full Text] [Related]
11. E2f1-3 are critical for myeloid development.
Trikha P; Sharma N; Opavsky R; Reyes A; Pena C; Ostrowski MC; Roussel MF; Leone G
J Biol Chem; 2011 Feb; 286(6):4783-95. PubMed ID: 21115501
[TBL] [Abstract][Full Text] [Related]
12. E2F2 represses cell cycle regulators to maintain quiescence.
Infante A; Laresgoiti U; Fernández-Rueda J; Fullaondo A; Galán J; Díaz-Uriarte R; Malumbres M; Field SJ; Zubiaga AM
Cell Cycle; 2008 Dec; 7(24):3915-27. PubMed ID: 19066456
[TBL] [Abstract][Full Text] [Related]
13. Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis.
Zhou J; Cheng M; Wu M; Boriboun C; Jujo K; Xu S; Zhao TC; Tang YL; Kishore R; Qin G
J Mol Cell Cardiol; 2013 Jul; 60():68-71. PubMed ID: 23603666
[TBL] [Abstract][Full Text] [Related]
14. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
Opavsky R; Tsai SY; Guimond M; Arora A; Opavska J; Becknell B; Kaufmann M; Walton NA; Stephens JA; Fernandez SA; Muthusamy N; Felsher DW; Porcu P; Caligiuri MA; Leone G
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15400-5. PubMed ID: 17881568
[TBL] [Abstract][Full Text] [Related]
15. E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells.
Castillo DS; Campalans A; Belluscio LM; Carcagno AL; Radicella JP; Cánepa ET; Pregi N
Cell Cycle; 2015; 14(8):1300-14. PubMed ID: 25892555
[TBL] [Abstract][Full Text] [Related]
16. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis.
Rempel RE; Mori S; Gasparetto M; Glozak MA; Andrechek ER; Adler SB; Laakso NM; Lagoo AS; Storms R; Smith C; Nevins JR
PLoS Genet; 2009 Sep; 5(9):e1000640. PubMed ID: 19749980
[TBL] [Abstract][Full Text] [Related]
17. E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop.
Timmers C; Sharma N; Opavsky R; Maiti B; Wu L; Wu J; Orringer D; Trikha P; Saavedra HI; Leone G
Mol Cell Biol; 2007 Jan; 27(1):65-78. PubMed ID: 17167174
[TBL] [Abstract][Full Text] [Related]
18. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation in the absence of E2F1-3.
Wenzel PL; Chong JL; Sáenz-Robles MT; Ferrey A; Hagan JP; Gomez YM; Rajmohan R; Sharma N; Chen HZ; Pipas JM; Robinson ML; Leone G
Dev Biol; 2011 Mar; 351(1):35-45. PubMed ID: 21185283
[TBL] [Abstract][Full Text] [Related]
20. Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma.
Kent LN; Bae S; Tsai SY; Tang X; Srivastava A; Koivisto C; Martin CK; Ridolfi E; Miller GC; Zorko SM; Plevris E; Hadjiyannis Y; Perez M; Nolan E; Kladney R; Westendorp B; de Bruin A; Fernandez S; Rosol TJ; Pohar KS; Pipas JM; Leone G
J Clin Invest; 2017 Mar; 127(3):830-842. PubMed ID: 28134624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
